D. Rehder, The potentiality of vanadium in medicinal applications, Future Medicinal Chemistry, vol.4, issue.14, pp.1823-1837, 2012.
DOI : 10.4155/fmc.12.103

D. Rehder, Bioinorganic Vanadium Chemistry, 2008.
DOI : 10.1002/9780470994429

K. H. Thompson, J. Lichter, C. Lebel, M. C. Scaife, J. H. Mcneil et al., Vanadium treatment of type 2 diabetes: A view to the future, Journal of Inorganic Biochemistry, vol.103, issue.4, pp.554-558, 2009.
DOI : 10.1016/j.jinorgbio.2008.12.003

H. Sakurai, Y. Kojima, Y. Yoshikawa, K. Kawabe, and H. Yasui, Antidiabetic vanadium(IV) and zinc(II) complexes, Coordination Chemistry Reviews, vol.226, issue.1-2, pp.187-198, 2002.
DOI : 10.1016/S0010-8545(01)00447-7

T. Jakusch, J. Costa-pessoa, and T. Kiss, The speciation of vanadium in human serum, Coordination Chemistry Reviews, vol.255, issue.19-20, pp.2218-2226, 2011.
DOI : 10.1016/j.ccr.2011.02.022

A. M. Evangelou, Vanadium in cancer treatment, Critical Reviews in Oncology/Hematology, vol.42, issue.3, pp.249-265, 2002.
DOI : 10.1016/S1040-8428(01)00221-9

R. A. Sánchez-delgado, A. Anzellotti, and L. Suárez, Metal ions in biological systems, 41: Metal Ions and their Complexes in Medication, pp.379-419, 2004.

H. Cerecetto and M. González, Synthetic Medicinal Chemistry in Chagas??? Disease: Compounds at The Final Stage of ???Hit-To-Lead??? Phase, Pharmaceuticals, vol.3, issue.4, pp.810-838, 2010.
DOI : 10.3390/ph3040810

D. R. Moreira, A. C. Lima-leite, R. Ribeiro-dos-santos, and M. B. Soares, Approaches for the Development of New Anti-Trypanosoma cruzi Agents, Current Drug Targets, vol.10, issue.3, pp.212-231, 2009.
DOI : 10.2174/138945009787581140

S. P. Fricker, R. M. Mosi, B. R. Cameron, I. Baird, Y. Zhu et al., Metal compounds for the treatment of parasitic diseases, Journal of Inorganic Biochemistry, vol.102, issue.10, pp.1839-1845, 2008.
DOI : 10.1016/j.jinorgbio.2008.05.010

D. Gambino and L. Otero, Perspectives on what ruthenium-based compounds could offer in the development of potential antiparasitic drugs, Inorganica Chimica Acta, vol.393, pp.103-114, 2012.
DOI : 10.1016/j.ica.2012.05.028

M. Navarro, G. Gabbiani, L. Messori, and D. Gambino, Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives, Drug Discovery Today, vol.15, issue.23-24, pp.1070-1077, 2010.
DOI : 10.1016/j.drudis.2010.10.005

F. Dubar, J. Khalife, J. Brocard, D. Dive, and C. Biot, Ferroquine, an Ingenious Antimalarial Drug ???Thoughts on the Mechanism of Action, Molecules, vol.13, issue.11, pp.2900-2907, 2008.
DOI : 10.3390/molecules13112900

D. Dive and C. Biot, Ferrocene Conjugates of Chloroquine and other Antimalarials: the Development of Ferroquine, a New Antimalarial, ChemMedChem, vol.5, issue.639, pp.383-391, 2008.
DOI : 10.1002/cmdc.200700127

C. Biot, Ferroquine: A New Weapon in the Fight Against Malaria, Current Medicinal Chemistry -Anti-Infective Agents, vol.3, issue.2, pp.135-147, 2004.
DOI : 10.2174/1568012043354008

V. Delespaux and H. P. De-koning, Drugs and drug resistance in African trypanosomiasis, Drug Resistance Updates, vol.10, issue.1-2, pp.30-50, 2007.
DOI : 10.1016/j.drup.2007.02.004

J. A. Urbina, New insights in Chagas disease treatment, Drugs of the Future, vol.35, issue.5, pp.409-420, 2010.
DOI : 10.1358/dof.2010.035.05.1484391

J. D. Maya, B. K. Cassels, P. Iturriaga-vásquez, J. Ferreira, M. Faúndez et al., Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host, Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol.146, issue.4, pp.601-620, 2007.
DOI : 10.1016/j.cbpa.2006.03.004

K. Nussbaum, J. Honek, C. M. Cadmus, and T. Efferth, Trypanosomatid Parasites Causing Neglected Diseases, Current Medicinal Chemistry, vol.17, issue.15, pp.1594-1617, 2010.
DOI : 10.2174/092986710790979953

S. Croft, M. Barret, and J. Urbina, Chemotherapy of trypanosomiases and leishmaniasis, Trends in Parasitology, vol.21, issue.11, pp.508-512, 2005.
DOI : 10.1016/j.pt.2005.08.026

K. Kinnamon, E. A. Steck, and E. S. Rane, Activity of Antitumor Drugs Against African Trypanosomes, Antimicrobial Agents and Chemotherapy, vol.15, issue.2, pp.157-160, 1979.
DOI : 10.1128/AAC.15.2.157

J. Benítez, L. Guggeri, I. Tomaz, G. Arrambide, M. Navarro et al., Design of vanadium mixed-ligand complexes as potential anti-protozoa agents, Journal of Inorganic Biochemistry, vol.103, issue.4, pp.609-616, 2009.
DOI : 10.1016/j.jinorgbio.2008.10.018

J. Benítez, L. Guggeri, I. Tomaz, J. Costa-pessoa, V. Moreno et al., A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: A potential anti-protozoa and anti-tumor agent, Journal of Inorganic Biochemistry, vol.103, issue.10, pp.1386-1394, 2009.
DOI : 10.1016/j.jinorgbio.2009.07.013

J. Benítez, L. Becco, I. Correia, S. M. Leal, H. Guiset et al., Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: New achievements, Journal of Inorganic Biochemistry, vol.105, issue.2, pp.303-311, 2011.
DOI : 10.1016/j.jinorgbio.2010.11.001

J. Rivadeneira, D. Barrio, G. Arrambide, D. Gambino, L. Bruzzone et al., Biological effects of a complex of vanadium(V) with salicylaldehyde semicarbazone in osteoblasts in culture: Mechanism of action, Journal of Inorganic Biochemistry, vol.103, issue.4, pp.633-642, 2009.
DOI : 10.1016/j.jinorgbio.2008.11.009

D. Gambino, M. Fernández, D. Santos, G. A. Etcheverría, O. E. Piro et al., Searching for gallium bioactive compounds: Gallium(III) complexes of tridentate salicylaldehyde semicarbazone derivatives, Polyhedron, vol.30, issue.7, pp.1360-1366, 2011.
DOI : 10.1016/j.poly.2011.02.037

W. J. Geary, The use of conductivity measurements in organic solvents for the characterisation of coordination compounds, Coordination Chemistry Reviews, vol.7, issue.1, pp.81-91, 1971.
DOI : 10.1016/S0010-8545(00)80009-0

A. Rockenbauer and L. Korecz, Automatic computer simulations of ESR spectra, Applied Magnetic Resonance, vol.38, issue.1-3, pp.29-43, 1996.
DOI : 10.1007/BF03163097

L. Casella, M. Gullotti, A. Pintar, S. Colonna, and A. Manfredi, Synthesis, characterization and catalytic oxidations of oxovanadium(IV), oxotitanium(IV) and dioxomolybdenum(VI) complexes with chiral imines of L-amino acids, Inorganica Chimica Acta, vol.144, issue.1, pp.89-97, 1988.
DOI : 10.1016/S0020-1693(00)80971-8

O. D. Crysalispro and . Ltd, Version 1.171, pp.48-63, 2009.

G. M. Sheldrick, SHELXS-97, Program for Crystal Structure Resolution, 1997.

G. M. Sheldrick, SHELXL-97, Program for Crystal Structures Analysis, 1997.

H. Hirumi and K. Hirumi, Continuous Cultivation of Trypanosoma brucei Blood Stream Forms in a Medium Containing a Low Concentration of Serum Protein without Feeder Cell Layers, The Journal of Parasitology, vol.75, issue.6, pp.985-989, 1989.
DOI : 10.2307/3282883

C. Hansch and A. Leo, The hydrophobic parameter: measurement and calculation, Exploring QSAR, Fundamentals and Applications in Chemistry and Biology, pp.97-124, 1995.

M. Vieites, P. Buccino, L. Otero, M. González, O. E. Piro et al., Chemo-selective hydrolysis of the iminic moiety in salicylaldehyde semicarbazone promoted by ruthenium, Inorganica Chimica Acta, vol.358, issue.11, pp.3065-3074, 2005.
DOI : 10.1016/j.ica.2005.04.021

S. Nica, M. Rudolph, H. Gorls, and W. Plass, Structural characterization and electrochemical behavior of oxovanadium(V) complexes with N-salicylidene hydrazides, Inorganica Chimica Acta, vol.360, issue.5, pp.1743-1752, 2007.
DOI : 10.1016/j.ica.2006.09.018

T. Ghosh, B. Mondal, M. Sutradhar, G. Mukherjee, and M. G. Drew, Synthesis, structure, solution chemistry and the electronic effect of para substituents on the vanadium center in a family of mixed-ligand [VVO(ONO)(ON)] complexes, Inorganica Chimica Acta, vol.360, issue.5, pp.1753-1761, 2007.
DOI : 10.1016/j.ica.2006.10.003

C. K. Johnson and . Ortep-ii, A Fortran Thermal-Ellipsoid Plot Program, 1976.

T. S. Smith, I. , R. Lobrutto, and V. L. Pecoraro, Paramagnetic spectroscopy of vanadyl complexes and its applications to biological systems, Coordination Chemistry Reviews, vol.228, issue.1, pp.1-18, 2002.
DOI : 10.1016/S0010-8545(01)00437-4

K. Wuthrich, -Komplexverbindungen in w??sseriger L??sung II, Helvetica Chimica Acta, vol.32, issue.5, pp.1012-1017, 1965.
DOI : 10.1002/hlca.19650480504

URL : https://hal.archives-ouvertes.fr/hal-00986964

G. Micera, V. L. Pecoraro, and E. Garribba, Pyridine Complexes, Inorganic Chemistry, vol.48, issue.13, pp.5790-5796, 2009.
DOI : 10.1021/ic9001779

E. H. Kerns and L. Di, Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, 2008.

G. B. Onoa, G. Cervantes, V. Moreno, and M. J. Prieto, Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy, Nucleic Acids Research, vol.26, issue.6, pp.1473-1480, 1998.
DOI : 10.1093/nar/26.6.1473

M. Vieites, P. Smircich, M. Pagano, L. Otero, F. Fischer et al., DNA as molecular target of analogous palladium and platinum anti-Trypanosoma cruzi compounds: A comparative study, Journal of Inorganic Biochemistry, vol.105, issue.12, pp.1704-1711, 2011.
DOI : 10.1016/j.jinorgbio.2011.07.018